Superworth

Filana Therapeutics EPS FLNA

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Dec 31, 2025
−$1.88
Latest quarter, Q4 FY25
−$0.26
Fiscal year 2025
−$1.88

Filana Therapeutics' earnings per share was −$1.88 over the twelve months to Dec 31, 2025.

In its latest quarter, Q4 FY25, it was −$0.26.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.88n/a
FY2024−$1.45n/a
FY2023−$2.32n/a
FY2021−$0.81n/a
FY2020−$0.25n/a
FY2019−$0.26n/a
FY2018−$0.84n/a
FY2017−$1.83n/a
FY2016−$2.33n/a
FY2015−$2.17n/a
FY2014−$1.96−141%
FY2013$4.83n/a
FY2012−$0.49n/a
FY2011−$0.42n/a
FY2010n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q4 FY25−$0.26n/a−$1.88
Q3 FY25−$0.22n/a−$2.19
Q2 FY25−$0.92−808%−$2.55
Q1 FY25−$0.48n/a−$1.50
Q4 FY24−$0.57n/a−$1.45
Q3 FY24−$0.58n/a−$1.38
Q2 FY24$0.13n/a−$1.41
Q1 FY24−$0.43n/a−$2.17
Q4 FY23−$0.50n/a−$2.32
Q3 FY23−$0.61n/an/a
Q2 FY23−$0.63n/an/a
Q1 FY23−$0.58n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Filana Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
FLNAFilana Therapeuticsn/m
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Filana Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.